Gilead Sciences (NASDAQ:GILD) Given New $95.00 Price Target at Barclays
Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective raised by Barclays from $84.00 to $95.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has an equal weight rating on the biopharmaceutical company’s stock. Other research analysts have also issued research reports about the company. Sanford C. Bernstein started coverage on […]
More Stories
Here Are the Countries That Have Reached, or Are Considering, Deportation Deals With US
By Savannah Hulsey Pointer President Donald Trump’s illegal immigrant deportation push has officials looking for new places to put illegal...
Focus Partners Wealth Invests $193,000 in D-Wave Quantum Inc. (NYSE:QBTS)
Focus Partners Wealth purchased a new position in D-Wave Quantum Inc. (NYSE:QBTS – Free Report) during the 4th quarter, Holdings...
Sanford C. Bernstein Cuts Palo Alto Networks (NASDAQ:PANW) Price Target to $225.00
Palo Alto Networks (NASDAQ:PANW – Free Report) had its target price cut by Sanford C. Bernstein from $229.00 to $225.00...
Home Depot (NYSE:HD) Upgraded at Stifel Nicolaus
Stifel Nicolaus upgraded shares of Home Depot (NYSE:HD – Free Report) from a hold rating to a buy rating in...
Deutsche Bank AG Acquires 15,258 Shares of Enerpac Tool Group Corp. (NYSE:EPAC)
Deutsche Bank AG raised its holdings in shares of Enerpac Tool Group Corp. (NYSE:EPAC – Free Report) by 45.8% during...
Janus Henderson Group PLC Has $888,000 Stock Position in GFL Environmental Inc. (NYSE:GFL)
Janus Henderson Group PLC reduced its holdings in shares of GFL Environmental Inc. (NYSE:GFL – Free Report) by 77.0% in...